DailyIQ
|
Sector:Financial ServicesAll sectors
Last updated 2 minutes ago

WRB·W. R. Berkley Corporation

$.
+. (+.%)
After Hours
High
$72.22
Open
$71.76
Market Cap
26.83B
52W High
$78.96
Low
$71.59
P. Close
$72.18
P/E
14.30
52W Low
$62.87
Fwd P/E
15.07
DailyIQ Est.
$63.86
Technical Score (1D)
95
BUY
News Sentiment
76
BULLISH
Wells Fargo’s most recent upgrade—raising WR B’s target to $67 from $58 while keeping an underweight rating—reflects confidence that the insurer’s underwriting performance and potential for premium growth will strengthen over the next few weeks, a sentiment that could lift the stock in the short term. The underweight stance tempers enthusiasm, indicating that valuation multiples still raise concerns. Cantor Fitzgerald’s parallel lift to $74, citing optimism about high‑margin specialty lines, reinforces the view that WR B’s core business is poised for growth. UBS and Mizuho followed suit, raising targets to $71 and $72 respectively and maintaining hold or neutral ratings, which signals a broader consensus that the company is undervalued relative to its earnings potential. The convergence of higher targets across firms points to a belief that WR B’s underwriting performance and capital structure are solid enough to support a higher valuation. Over the next 1–10 trading days, traders should watch for the upcoming earnings release to see if loss ratios and capital allocation align with the optimistic outlook. Pay particular attention to the policy renewal cycle and any regulatory updates that could affect underwriting profitability, as these are cited as key catalysts by several analysts. If the earnings report confirms improved loss experience and capital efficiency, the stock could see a short‑term rally; if not, the market may reassess the higher price targets.
Earnings Summary
W.R. Berkley Corporation is a global insurance holding company focused on commercial lines insurance, operating through its Insurance and Reinsurance & Monoline Excess segments, and serving diverse industries with excess, surplus, specialty personal, and accident and health coverage. In the most recent quarter, the company reported Q4 2025 earnings of $1.13 per share versus an estimate of $1.1383, and revenue of $3.715 billion against an estimate of $3.697 billion, marking a modest revenue decline from Q3 2025’s $3.156 billion but an EPS increase from $1.10. Compared to the prior two quarters (Q2 2025 $1.05 EPS, $3.098 billion revenue; Q3 2025 $1.10 EPS, $3.156 billion revenue), the company has accelerated EPS growth while revenue growth has decelerated, with Q4 2025 revenue up 19% from Q3 2025 but down 1.5% from Q4 2024. Over the last six quarters, WRB has beaten analyst EPS estimates in four quarters (Q4 2024, Q1 2025, Q2 2025, Q1 2026) and missed in two (Q3 2025, Q4 2025), indicating a generally positive earnings trajectory but some volatility around guidance. Year‑over‑year, revenue has grown roughly 23% from Q4 2024 to Q4 2025 and from Q1 2025 to Q1 2026, while EPS has remained flat in Q4 2025 and surged from $1.01 in Q1 2025 to $1.30 in Q1 2026, underscoring a trend of improving profitability despite revenue fluctuations. Recent analyst activity has seen multiple upgrades—Wells Fargo, Cantor Fitzgerald, UBS, Mizuho, and Keefe, Bruyette & Woods—all raising price targets to the $67–$74 range and citing confidence in underwriting performance, capital structure, and potential premium growth; these upgrades suggest market optimism that could lift the stock if the upcoming earnings release confirms improved loss ratios and capital efficiency. Investors should watch for the Q2 2026 earnings release, focusing on loss‑ratio trends, policy renewal cycles, reinsurance agreements, and any regulatory updates that could impact underwriting profitability, as these factors will be key to validating the optimistic valuation consensus and determining the next move in the stock’s price trajectory.

EPS

EstBeatMiss
$0.94$1.04$1.14$1.25$1.35Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.09 - -
Q1'26$1.16$1.30+12.1%
Q4'25$1.14$1.13-0.7%
Q3'25$1.10$1.10-0.3%
Q2'25$1.02$1.05+2.5%
Q1'25$0.99$1.01+2.4%

Revenue

EstBeatMiss
$2.9B$3.2B$3.4B$3.7B$3.9BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$3.8B - -
Q1'26$3.8B$3.7B-2.4%
Q4'25$3.7B$3.7B+0.5%
Q3'25 - $3.2B -
Q2'25 - $3.1B -
Q1'25 - $3.0B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

WRB Stock Snapshot

WRB is currently trading at $72.19, giving W. R. Berkley Corporation a market cap of 26.83B and a P/E ratio of 14.3. Today's range spans $71.59–$72.22, with shares opening at $71.76 and moving up $0.01 (0.0%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 76/100.

Over the past year WRB has traded between $62.87 and $78.96 - the current price is +14.8% off the 52-week low and -8.6% from the high. 29 analysts cover the stock with a Hold consensus and a mean 12-month target of $67.24 (range $51.00–$78.00), implying downside of -6.9%.

If you're looking for bullish momentum in Financial Services, WRB is putting up the numbers: 95/100 technical score, BUY signal, bullish sentiment at 76/100. Price: $72.19 (in the middle of its 52-week range). (P/E: 14.3) The 26.83B market cap keeps it in play for institutional position sizes, and the $62.87–$78.96 annual range shows this stock can make real moves when it gets directional conviction behind it.

The combination of a BUY signal (95/100) and bullish news sentiment (76/100) puts WRB on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 26.83B in Financial Services market cap without immediately moving the stock. At $72.19 (in the middle of its 52-week range in the $62.87–$78.96 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.